168 related articles for article (PubMed ID: 26617750)
21. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
[TBL] [Abstract][Full Text] [Related]
22. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
Yang Y; Quan L; Ling Y
Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
[TBL] [Abstract][Full Text] [Related]
23. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
24. EIF3D promotes the progression of preeclampsia by inhibiting of MAPK/ERK1/2 pathway.
Li X; Wang Z; Liu G; Guo J
Reprod Toxicol; 2021 Oct; 105():166-174. PubMed ID: 34520790
[TBL] [Abstract][Full Text] [Related]
25. Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function.
Pan Y; Zhang ZN; Yin LB; Fu YJ; Jiang YJ; Shang H
J Transl Med; 2019 May; 17(1):167. PubMed ID: 31118081
[TBL] [Abstract][Full Text] [Related]
26. High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/β-catenin signalling.
Jiang J; Wang J; He X; Ma W; Sun L; Zhou Q; Li M; Yu S
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):597-606. PubMed ID: 30854682
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Eukaryotic translation initiation factor 3D induces stem cell-like properties and metastasis in cervix cancer by activating FAK through inhibiting degradation of GRP78.
Zhong Y; Lan J
Bioengineered; 2022 Jan; 13(1):1952-1961. PubMed ID: 35104170
[TBL] [Abstract][Full Text] [Related]
28. Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer BT474 cells.
Wang R; Li Z; Guo H; Shi W; Xin Y; Chang W; Huang T
Mol Med Rep; 2014 May; 9(5):1723-8. PubMed ID: 24604116
[TBL] [Abstract][Full Text] [Related]
29. β-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells.
Wang SH; Li N; Wei Y; Li QR; Yu ZP
Mol Med Rep; 2014 Mar; 9(3):973-8. PubMed ID: 24401947
[TBL] [Abstract][Full Text] [Related]
30. KNOCKDOWN OF CASEIN KINASE 1e INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/β-CATENIN SIGNALING.
Ye LC; Jiang C; Bai J; Jiang J; Hong HF; Qiu LS
J Biol Regul Homeost Agents; 2015; 29(2):307-15. PubMed ID: 26122218
[TBL] [Abstract][Full Text] [Related]
31. [Knockdown of CART1 induces S phase arrest and inhibits invasion and migration of MDA-MB-231 breast cancer cells].
Guan T; Su L; Yi Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):474-8. PubMed ID: 27053613
[TBL] [Abstract][Full Text] [Related]
32. Dickkopf 2 promotes proliferation and invasion via Wnt signaling in prostate cancer.
Xu W; Pang K; Zhou ZG; Chen YF; Mo T; Li M; Liu CB
Mol Med Rep; 2016 Sep; 14(3):2283-8. PubMed ID: 27431620
[TBL] [Abstract][Full Text] [Related]
33. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
Lu D; Mihoayi M; Ablikim Y; Arikin A
Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
[TBL] [Abstract][Full Text] [Related]
34. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
35. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
36. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
[TBL] [Abstract][Full Text] [Related]
38. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
Fillmore RA; Mitra A; Xi Y; Ju J; Scammell J; Shevde LA; Samant RS
Int J Cancer; 2009 Aug; 125(3):556-64. PubMed ID: 19358268
[TBL] [Abstract][Full Text] [Related]
39. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition effect of β-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cells.
Xu WL; Wang Q; Du M; Zhao YH; Sun XR; Sun WG; Chen BQ
Cancer Biother Radiopharm; 2010 Oct; 25(5):529-37. PubMed ID: 20950152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
